{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:21:18Z","timestamp":1791062478656,"version":"4.1.0"},"reference-count":81,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1080\/10673220902899722","type":"journal-article","created":{"date-parts":[[2009,4,16]],"date-time":"2009-04-16T20:08:49Z","timestamp":1239912529000},"page":"138-146","source":"Crossref","is-referenced-by-count":37,"title":["Reproductive and Metabolic Abnormalities Associated with Bipolar Disorder and Its Treatment"],"prefix":"10.1097","volume":"17","author":[{"given":"Heather A.","family":"Kenna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie L.","family":"Rasgon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1586\/14737175.8.1.93","article-title":"Neurobiology of bipolar disorder.","volume":"8","author":"Newberg","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0025-7125(16)30744-1","article-title":"Biology of depression.","volume":"72","author":"Rothschild","year":"1988","journal-title":"Med Clin North Am"},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4088\/JCP.v61n0305","article-title":"Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report.","volume":"61","author":"Rasgon","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1399-5618.2005.00201.x","article-title":"Reproductive function and risk for PCOS in women treated for bipolar disorder.","volume":"7","author":"Rasgon","year":"2005","journal-title":"Bipolar Disord"},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1399-5618.2003.00010.x","article-title":"Menstrual cycle related mood changes in women with bipolar disorder.","volume":"5","author":"Rasgon","year":"2003","journal-title":"Bipolar Disord"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4088\/JCP.v63n0409","article-title":"Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder.","volume":"63","author":"ODonovan","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1034\/j.1399-5618.2003.00009.x","article-title":"Valproate, bipolar disorder and polycystic ovarian syndrome.","volume":"5","author":"McIntyre","year":"2003","journal-title":"Bipolar Disord"},{"key":"R8-6-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0278-5846(02)00341-X","article-title":"Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women.","volume":"27","author":"Akdeniz","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R9-6-20210129","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jad.2005.08.002","article-title":"Longitudinal evaluation of reproductive function in women treated for bipolar disorder.","volume":"89","author":"Rasgon","year":"2005","journal-title":"J Affect Disord"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.biopsych.2005.10.017","article-title":"Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.","volume":"59","author":"Joffe","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4088\/JCP.v67n0218","article-title":"Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls.","volume":"67","author":"Joffe","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"suppl 4","key":"R12-6-20210129","first-page":"8","article-title":"Antipsychotic medications; metabolic and cardiovascular risk.","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1528-1167.2006.00506.x","article-title":"Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy.","volume":"47","author":"Lofgren","year":"2006","journal-title":"Epilepsia"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"635","DOI":"10.12968\/bjon.2006.15.12.21393","article-title":"Symptoms and treatments of polycystic ovary syndrome.","volume":"15","author":"Banning","year":"2006","journal-title":"J Br Nurs"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.2174\/092986707782360088","article-title":"Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review.","volume":"14","author":"Reynolds","year":"2007","journal-title":"Curr Med Chem"},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1399-5618.2003.00089.x","article-title":"Special considerations in treating bipolar disorder in women.","volume":"6","author":"Burt","year":"2004","journal-title":"Bipolar Disord"},{"key":"R18-6-20210129","first-page":"825","article-title":"Elevated serum LH and androgens in affective disorder related to the menstrual cycle: with reference to polycystic ovary syndrome.","volume":"47","author":"Matsunaga","year":"1993","journal-title":"J Jpn Psychiatry Neurol"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","article-title":"M, Myllyla V V. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.","volume":"329","author":"Isojarvi","year":"1993","journal-title":"N J Engl Med"},{"key":"R20-6-20210129","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410430406","article-title":"Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.","volume":"43","author":"Isojarvi","year":"1998","journal-title":"Ann Neurol"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4088\/JCP.v63n0409","article-title":"Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder.","volume":"63","author":"ODonovan","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R22-6-20210129","doi-asserted-by":"crossref","first-page":"33s","DOI":"10.1016\/S0002-9343(99)80057-6","article-title":"Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.","volume":"98","author":"Dunaif","year":"1995","journal-title":"J Am Med"},{"key":"R23-6-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.21411","article-title":"J, Hayes F J, Sluss P M, et al. Hyperandrogenism, ovulatory dysfunction, and polycystic ovary syndrome with valproate versus lamotrigine.","volume":"64","author":"Morrell","year":"2008","journal-title":"Ann Neurol"},{"key":"R24-6-20210129","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11920-007-0071-1","article-title":"N. Weight gain and metabolic issues of medicines used for bipolar disorder.","volume":"9","author":"Fagiolini","year":"2007","journal-title":"Curr Psychiatry Rep"},{"key":"R25-6-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4088\/JCP.v61n0306","article-title":"L, Silverstone J T, Mann J I, Williams S M, Romans S E. Prevalence of overweight and obesity in bipolar patients.","volume":"61","author":"Elmslie","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R26-6-20210129","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/00007611-199909000-00009","article-title":"J, Bartlett S J, Zayas R, Twilley C H, Allison D B, Contoreggi C. Prescription medications: a modifiable contributor to obesity.","volume":"92","author":"Cheskin","year":"1999","journal-title":"South J Med"},{"key":"R27-6-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jad.2007.12.233","article-title":"Prevalence and correlates of overweight in drug-naive patients with bipolar disorder.","volume":"110","author":"Maina","year":"2008","journal-title":"J Affect Disord"},{"key":"R28-6-20210129","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4088\/JCP.v67n0704","article-title":"Associations between bipolar disorder and metabolic syndrome: a review.","volume":"67","author":"Taylor","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"suppl 9","key":"R29-6-20210129","first-page":"35","article-title":"Efficacy of lithium in mania and maintenance therapy of bipolar disorder.","volume":"61","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R30-6-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0165-0327(80)90031-2","article-title":"D, Dunner D L, Fieve R R, Lautin A. Lithium carbonate and weight gain.","volume":"2","author":"Peselow","year":"1980","journal-title":"J Affect Disord"},{"key":"R31-6-20210129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archpsyc.57.5.481","article-title":"A randomized, placebo-controlled 12 month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder.","volume":"57","author":"Bowden","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R32-6-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0447.1980.tb00607.x","article-title":"Clinically significant side effects of lithium treatment. A survey of 237 patients in long-term treatment.","volume":"62","author":"Vestergaard","year":"1980","journal-title":"Acta Psychiatr Scand"},{"key":"R34-6-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-979586","article-title":"Lithium and body weight gain.","volume":"28","author":"Baptista","year":"1995","journal-title":"Pharmacopsychiatry"},{"key":"R35-6-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0269881105057515","article-title":"Lithium: a review of its metabolic adverse effects.","volume":"20","author":"Livingstone","year":"2006","journal-title":"J Psychopharmacol"},{"key":"R36-6-20210129","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1600-0447.1988.tb06363.x","article-title":"Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints.","volume":"78","author":"Vestergaard","year":"1988","journal-title":"Acta Psychiatr Scand"},{"key":"R37-6-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0447.1976.tb00067.x","article-title":"B, Bech P, Rafaelsen O J. Lithium treatment and weight gain.","volume":"53","author":"Vendsborg","year":"1976","journal-title":"Acta Psychiatr Scand"},{"key":"R38-6-20210129","first-page":"355","article-title":"Lithium-induced changes in body mass index.","volume":"53","author":"Mathew","year":"1976","journal-title":"Acta Psychiatr Scand"},{"key":"R39-6-20210129","first-page":"104","article-title":"Lithium side-effects and predictors of hypothyroidism in patients with bipolar disorder: sex differences.","volume":"27","author":"Henry","year":"2002","journal-title":"J Psychiatry Neurosci"},{"key":"R40-6-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnpbp.2007.06.018","article-title":"Lithium increases gastrointestinal tract weight of male or female rats but it increases body weight only in females.","volume":"32","author":"Levine","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R41-6-20210129","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archpsyc.1969.01740220094011","article-title":"Manic-depressive illness, diabetes mellitus, and lithium carbonate.","volume":"21","author":"van d er, Velde","year":"1969","journal-title":"Arch Gen Psychiatry"},{"key":"R42-6-20210129","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0447.1972.tb04373.x","article-title":"T, Thomsen H G, Bjorum N, Rafaelsen O J. Lithium, weight gain, and serum insulin in manic-depressive patients.","volume":"48","author":"Mellerup","year":"1972","journal-title":"Acta Psychiatr Scand"},{"key":"R43-6-20210129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0447.1973.tb04451.x","article-title":"Lithium in man: effect on glucose tolerance and serum electrolytes.","volume":"49","year":"1973","journal-title":"Acta Psychiatr Scand"},{"key":"R44-6-20210129","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1600-0447.1988.tb06375.x","article-title":"V, Godleski L S, Hundley P L, Yank G R. Lithium, polyuria and abnormal diurnal weight gain in psychosis.","volume":"78","author":"Vieweg","year":"1988","journal-title":"Acta Psychiatr Scand"},{"key":"R45-6-20210129","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0026-0495(92)90061-E","article-title":"Metabolic changes during treatment with valproate in humans: implication for untoward weight gain.","volume":"41","author":"Breum","year":"1992","journal-title":"Metabolism"},{"key":"R46-6-20210129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/026988119801200410","article-title":"Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats.","volume":"12","year":"1998","journal-title":"J Psychopharmacol"},{"key":"R47-6-20210129","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/00002018-200124130-00004","article-title":"Bodyweight gain and anticonvulsants: a comparative review.","volume":"24","author":"Jallon","year":"2001","journal-title":"Drug Saf"},{"key":"R48-6-20210129","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.seizure.2006.12.009","article-title":"Valproate, weight gain and carbohydrate craving: a gender study.","volume":"16","author":"El-Khatib","year":"2007","journal-title":"Seizure"},{"key":"R49-6-20210129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0009-8981(85)90020-8","article-title":"S, Bohan T P, Roe C R, Yergey A L, Liberato D J. Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography-mass spectrometry.","volume":"145","author":"Millington","year":"1985","journal-title":"Clin Chim Acta"},{"key":"R50-6-20210129","first-page":"314","article-title":"Hyperammonemia in valproate therapy in children and adolescents.","volume":"57","year":"1986","journal-title":"Nervenarzt"},{"key":"R51-6-20210129","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity.","volume":"43","author":"Pylvanen","year":"2002","journal-title":"Epilepsia"},{"key":"R52-6-20210129","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1528-1157.2001.0420081002.x","article-title":"Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.","volume":"42","author":"Stephen","year":"2001","journal-title":"Epilepsia"},{"key":"R53-6-20210129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0447.1992.tb01453.x","article-title":"Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder.","volume":"85","author":"Coxhead","year":"1992","journal-title":"Acta Psychiatr Scand"},{"key":"R54-6-20210129","first-page":"313","article-title":"T, Post R M, Uhde T W. Effect of carbamazepine on body weight in affectively ill patients.","volume":"47","author":"Joffe","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"R55-6-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1517\/14728222.12.1.81","article-title":"Topiramate and type 2 diabetes: an old wine in a new bottle.","volume":"12","author":"Khanna","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"R56-6-20210129","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1345\/aph.1H178","article-title":"Topiramate for binge-eating disorder associated with obesity.","volume":"40","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R57-6-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11920-006-0056-5","article-title":"M, Altshuler L L, Frye M A, et al. New findings from the Bipolar Collaborative Network: clinical implications for therapeutics.","volume":"8","author":"Post","year":"2006","journal-title":"Curr Psychiatry Rep"},{"issue":"suppl 1","key":"R58-6-20210129","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects.","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"R60-6-20210129","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1399-5618.2007.00520.x","article-title":"Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.","volume":"10","author":"van Winkel","year":"2008","journal-title":"Bipolar Disord"},{"key":"R61-6-20210129","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-5618.2005.00234.x","article-title":"A, Turkin S, Kupfer D J. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians.","volume":"7","author":"Fagiolini","year":"2005","journal-title":"Bipolar Disord"},{"key":"R62-6-20210129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jad.2007.06.002","article-title":"The prevalence of metabolic syndrome in patients with bipolar disorder.","volume":"106","author":"Garcia-Portilla","year":"2008","journal-title":"J Affect Disord"},{"key":"R63-6-20210129","first-page":"270","article-title":"Mental disorders, treatment response, mortality and serum cholesterol: a new holistic look at old data.","volume":"19","author":"Jakovljevic","year":"2007","journal-title":"Psychiatr Danub"},{"key":"R64-6-20210129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"R65-6-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2006.08.009","article-title":"Atypical antipsychotics related metabolic syndrome in bipolar patients.","volume":"98","author":"Yumru","year":"2007","journal-title":"J Affect Disord"},{"key":"R66-6-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.05.030","article-title":"A, Marusak S L, et al. Modal subcomponents of metabolic syndrome in patients with bipolar disorder.","volume":"106","author":"Cardenas","year":"2008","journal-title":"J Affect Disord"},{"key":"R67-6-20210129","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1590\/S1516-44462007000400007","article-title":"The prevalence of metabolic syndrome among psychiatric inpatients in Brazil.","volume":"29","year":"2007","journal-title":"Rev Bras Psiquiatr"},{"key":"R68-6-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0920-1211(03)00091-3","article-title":"Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients.","volume":"55","author":"Luef","year":"2003","journal-title":"Epilepsy Res"},{"key":"R69-6-20210129","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy.","volume":"39","author":"Isojarvi","year":"1996","journal-title":"Ann Neurol"},{"key":"R70-6-20210129","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.pnpbp.2007.03.003","article-title":"Y, Lee H C, Chen C C. Hyperinsulinaemia associated with beta-adrenoceptor antagonist in medicated bipolar patients during manic episode.","volume":"31","author":"Tsai","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R71-6-20210129","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0006-3223(97)00274-6","article-title":"Plasma dexamethasone concentration and cortisol response during manic episodes.","volume":"43","author":"Cassidy","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R72-6-20210129","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/cs0770453","article-title":"Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis.","volume":"77","author":"Brindley D N, Rolland","year":"1989","journal-title":"Clin Sci (Lond)"},{"key":"R73-6-20210129","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2337\/diab.46.4.717","article-title":"Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance.","volume":"46","author":"Zakrzewska K E, Cusin","year":"1997","journal-title":"Diabetes"},{"key":"R74-6-20210129","first-page":"291","article-title":"The regulation of adipose tissue distribution in humans.","volume":"20","author":"Bjorntorp","year":"1996","journal-title":"J Int Obes Relat Metab Disord"},{"key":"R75-6-20210129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.","volume":"14","author":"DeFronzo R A, Ferrannini","year":"1991","journal-title":"Diabetes Care"},{"key":"R76-6-20210129","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/JCP.0b013e318166c4f7","article-title":"B, Birkeland K I, Engh J A, et al. Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions.","volume":"28","author":"Birkenaes","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R77-6-20210129","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000092219","article-title":"S, Savas H A, Celik A, et al. Atypical antipsychotic usage-related higher serum leptin levels and disabled lipid profiles in euthymic bipolar patients.","volume":"53","author":"Gergerlioglu","year":"2006","journal-title":"Neuropsychobiology"},{"key":"R78-6-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1176\/appi.ps.57.2.205","article-title":"C, Wilk J, West J C. Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia.","volume":"57","author":"Olfson","year":"2006","journal-title":"Psychiatr Serv"},{"key":"R79-6-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-2002-36391","article-title":"Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.","volume":"35","author":"Baptista","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"R80-6-20210129","doi-asserted-by":"crossref","first-page":"36824","DOI":"10.1074\/jbc.M505560200","article-title":"Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion.","volume":"280","author":"Rubi","year":"2005","journal-title":"J Biol Chem"},{"key":"R82-6-20210129","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00702-005-0284-6","article-title":"A prospective study of serum ghrelin levels in patients treated with clozapine.","volume":"112","author":"Theisen F M, Gebhardt","year":"2005","journal-title":"J Neural Transm"},{"key":"R83-6-20210129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00213-003-1642-4","article-title":"Serum ghrelin concentrations in patients receiving olanzapine or risperidone.","volume":"172","author":"Togo","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"R84-6-20210129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/01.chi.0000170552.15798.dd","article-title":"L, Bobb A J, Gogtay N, et al. Hormonal correlates of clozapine-induced weight gain in psychotic children: an exploratory study.","volume":"44","author":"Sporn","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R85-6-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.2007.56-b","article-title":"Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized clinical trial.","volume":"299","author":"Wu","year":"2008","journal-title":"JAMA"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00023727-200904000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:52Z","timestamp":1786038532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00023727-200904000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1080\/10673220902899722","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}